LGC Group

LGC Group is a global life science tools company that supplies mission-critical components and solutions used to diagnose, treat, feed and protect a growing population. Its work spans reference materials, proficiency testing and diagnostic components, with applications in pharmaceutical development, clinical diagnostics, food safety, environmental protection and public health. The company dates its origins to 1842, when it began as a UK government laboratory, and now sells products in more than 180 markets while operating in 14 countries.

Its activities are organised across several divisions. LGC Standards provides reference standards and materials; LGC Biosearch Technologies focuses on genomics and oligonucleotide and reagent solutions; LGC Clinical Diagnostics supplies clinical diagnostic solutions and quality controls; and Axolabs specialises in nucleic acid therapeutics. LGC also supplies essential components for PCR testing, including during the COVID-19 pandemic response. The broader technical remit covers supply chain assurance, quality control solutions and food safety testing.

Of roughly 3,800 employees, around 1,100 hold advanced degrees. Manufacturing facilities are registered with the EMA, the FDA or equivalent international bodies, reflecting the company's emphasis on quality and regulatory compliance. LGC describes its mission as advancing science for a safer world and works in partnership with customers across its markets.